What Thymalin is
Thymalin is described as a thymus-derived peptide complex discussed in aging, immune function, and resilience narratives.
Thymalin is grouped under Longevity + Skin on PeptideFactCheck because it shows up in longevity circles because it sounds like a peptide route to immune and aging support.
The useful starting point is to separate the molecule itself from the internet story around it. It shows up in longevity circles because it sounds like a peptide route to immune and aging support.
Why people keep looking it up
It shows up in longevity circles because it sounds like a peptide route to immune and aging support.
Thymalin is described as a thymus-derived peptide complex discussed in aging, immune function, and resilience narratives.
Thymalin tends to stay in the conversation because it touches a familiar public theme: immune signaling, thymus peptides, and aging discussion. That makes it easy for the claim to travel faster than the evidence.
What the evidence can support right now
Limited human history and a large amount of extrapolative longevity marketing.
There is older human literature, but not enough to support broad modern longevity claims with confidence.
The biology is mainly discussed through thymus-peptide and immune-signaling theory.
Why this page carries the current tier: Limited human history and a large amount of extrapolative longevity marketing.
The current seed trail for Thymalin is pulling from 1 literature source, 1 trials source, and 1 databases source.
Safety, limits, and regulatory context
Complex peptide extracts and aging claims are both areas where hype can outrun clarity quickly.
Thymalin is not FDA-approved in the current seed set.
Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for Thymalin. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.
Molecular and identifier data
The current PubChem match for Thymalin is CID 3085284. That gives the page a source-backed chemistry record rather than a placeholder identifier block.
- PubChem CID
- 3085284
- Formula
- C33H54N12O15
- Molecular weight
- 858.9
- InChIKey
- LIFNDDBLJFPEAN-BPSSIEEOSA-N
Matched synonyms include Nonathymulin, 63958-90-7, Nonathymulin [INN], Thymic factor, 9H198D04WL, (2S)-4-amino-2-[[(2S)-2-[[2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoic acid, Thymalin, ((S)-5-Oxopyrrolidine-2-carbonyl)-L-alanyl-L-lysyl-L-seryl-L-glutaminylglycylglycyl-L-seryl-L-asparagine.
Open PubChem recordClinical trial snapshot
The current ClinicalTrials.gov intervention query for Thymalin returns 8 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.
Literature snapshot
The current PubMed query for Thymalin returns 396 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.
Source trail
Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.